Next Article in Journal
Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?
Previous Article in Journal
Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD)
 
 
Review

Article Versions Notes

Livers 2022, 2(4), 283-314; https://doi.org/10.3390/livers2040023
Action Date Notes Link
article pdf uploaded. 14 October 2022 15:34 CEST Version of Record https://www.mdpi.com/2673-4389/2/4/23/pdf-vor
article supplementary file uploaded. 14 October 2022 15:34 CEST - https://www.mdpi.com/2673-4389/2/4/23#supplementary
article xml file uploaded 28 October 2022 12:48 CEST Original file -
article xml uploaded. 28 October 2022 12:48 CEST Update -
article pdf uploaded. 28 October 2022 12:48 CEST Updated version of record https://www.mdpi.com/2673-4389/2/4/23/pdf-vor
article html file updated 28 October 2022 12:50 CEST Original file -
article xml file uploaded 29 November 2022 06:26 CET Update -
article xml uploaded. 29 November 2022 06:26 CET Update https://www.mdpi.com/2673-4389/2/4/23/xml
article pdf uploaded. 29 November 2022 06:26 CET Updated version of record https://www.mdpi.com/2673-4389/2/4/23/pdf
article html file updated 29 November 2022 06:27 CET Update -
article html file updated 28 February 2023 18:10 CET Update -
article html file updated 1 March 2023 21:48 CET Update https://www.mdpi.com/2673-4389/2/4/23/html
Back to TopTop